宏利香港首季核心盈利按年增長1% 新業務價值跌20%
宏利香港公佈2022年第一季業績,核心盈利錄得17.1億元,按年增長1%,連續第19個季度錄得按年增長;年度化保費等值銷售額錄得13.1億元,按年減少23%;新造業務價值錄得9.1億元,按年減少20%。
新造業務價值邊際利潤按年上升3個百分點至69.1%;截至2022年3月31日,代理人數目達11,457人,較2021年第一季末增長7%。
截至2022年3月底,按管理資產計算,宏利的強積金市佔率爲26.9%,較去年第一季末增長2.2個百分點。2022年第一季期間,按預計現金淨流入計算,宏利的強積金市佔率爲37%。
宏利香港及澳門行政總裁戴明鈞表示,在新冠疫情的挑戰下,公司核心盈利、新造業務價值及年度化保費等值銷售額均超越2019年疫情前的水平,醫療保單銷售數目按年增長16%。在三月稅季結束前,售出的自願醫保計劃保單數目錄得按年30%的增幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.